Personalized heart failure medication adjustment with biomarker monitoring
Part of Heart & circulation clinical trials.
This study looks at how doctors adjust heart failure medications and uses simple blood tests (biomarkers) to see how well you respond. It aims to help fine-tune your treatment so you feel better and avoid hospital stays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have given your written consent to participate.
- You have been diagnosed with new or worsening heart failure and your heart's pumping ability (ejection fraction) is less than 50%.
- You are taking at least 40 mg of furosemide (or an equivalent water pill) daily.
- You are currently on less than half of the recommended dose of at least one heart failure medication, and your doctor plans to increase that dose.
- You are not on dialysis, do not have a mechanical heart pump, and are not scheduled for heart surgery or transplant in the near future.
- You are not pregnant or planning to become pregnant, and you have no other life-limiting conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
This trial tests a virtual “heart failure clinic” and home heart monitoring to help people manage symptoms and outcomes. It may help by catching problems earlier and guiding safer self-care between doctor visits.
This study tests whether a blood test can help doctors choose the best medication for people with chronic heart failure. It aims to improve symptom control and reduce hospital stays.
This study tests a personalized approach to safely increase the dose of your heart failure medication (beta-blocker). It aims to improve your symptoms and overall heart function by tailoring the dose to your specific needs.
This trial tests whether checking in remotely (telemonitoring) helps doctors adjust heart failure medications more effectively. It is for people newly diagnosed with heart failure who have reduced pumping strength and signs of fluid buildup.
This study tests a remote monitoring device that sends information to your care team to help adjust your heart failure medications. It aims to improve your condition after a hospital stay for heart failure.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.